Future costs in cost effectiveness analysis
- 31 July 2008
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 27 (4), 809-818
- https://doi.org/10.1016/j.jhealeco.2007.09.011
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The cost‐effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub‐study to the HOPE studyJournal of Internal Medicine, 2002
- Defining the value of a statistical life: a comment.Journal of Health Economics, 2002
- Is there a meaningful definition of the value of a statistical life?Journal of Health Economics, 2001
- Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in SwedenPharmacoEconomics, 2001
- Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus. Results from the DIGAMI studyPublished by Oxford University Press (OUP) ,2000
- Incorporating Future Costs in Medical Cost-Effectiveness AnalysisMedical Decision Making, 1997
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- Capital Accumulation and Uncertain Lifetimes with Adverse SelectionEconometrica, 1986
- On Uncertain LifetimesJournal of Political Economy, 1977